I guarantee weight loss would be on Dr T's list of potential uses of Bisantrene.
This is a grab from a global drug forecast and market analysis. As we can see, total expected sales in 2022 are (I'm assuming USD) USD $8.4 B. Another grab from a report states that "The Global Anti-obesity Prescription Drugs Market is expected to grow from USD 9,909.80 Million in 2019 to USD 16,094.08 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.41%".
It seems that any further information is limited, as many market analysts have looked into this, but there are few who are prepared to share their research for free.
Pillar 1 - FTO (new thread), page-32
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.010(0.76%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.31 | $1.23 | $212.1K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5201 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 9799 | 2 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.28 |
Change
-0.010 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.30 | $1.31 | $1.23 | 17594 | ||
| Last updated 15.52pm 29/04/2024 ? | |||||
| RAC (ASX) Chart |